These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 9345412)

  • 1. Guidelines for MRI monitoring of the treatment of multiple sclerosis: recommendations of the US Multiple Sclerosis Society's task force.
    Miller DH
    Mult Scler; 1996 Jul; 1(6):335-8. PubMed ID: 9345412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force.
    Miller DH; Albert PS; Barkhof F; Francis G; Frank JA; Hodgkinson S; Lublin FD; Paty DW; Reingold SC; Simon J
    Ann Neurol; 1996 Jan; 39(1):6-16. PubMed ID: 8572668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of magnetic resonance techniques in understanding and managing multiple sclerosis.
    Miller DH; Grossman RI; Reingold SC; McFarland HF
    Brain; 1998 Jan; 121 ( Pt 1)():3-24. PubMed ID: 9549485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroimaging in multiple sclerosis.
    Miller DH; McDonald WI
    Clin Neurosci; 1994; 2(3-4):215-24. PubMed ID: 7749891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI as an outcome in multiple sclerosis clinical trials.
    Daumer M; Neuhaus A; Morrissey S; Hintzen R; Ebers GC
    Neurology; 2009 Feb; 72(8):705-11. PubMed ID: 19073945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Is MRI monitoring useful in clinical practice in patients with multiple sclerosis? No].
    Edan G
    Rev Neurol (Paris); 2013 Nov; 169(11):864-8. PubMed ID: 24125462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic resonance in monitoring the treatment of multiple sclerosis.
    Miller DH
    Ann Neurol; 1994; 36 Suppl():S91-4. PubMed ID: 8017895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple sclerosis: use of MRI in evaluating new therapies.
    Miller DH
    Semin Neurol; 1998; 18(3):317-25. PubMed ID: 9817536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of magnetization transfer ratio-derived pial and subpial abnormalities in the multiple sclerosis spinal cord.
    Kearney H; Yiannakas MC; Samson RS; Wheeler-Kingshott CA; Ciccarelli O; Miller DH
    Brain; 2014 Sep; 137(Pt 9):2456-68. PubMed ID: 24966048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Future MRI tools in multiple sclerosis.
    Filippi M; Absinta M; Rocca MA
    J Neurol Sci; 2013 Aug; 331(1-2):14-8. PubMed ID: 23706475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of tissue damage in multiple sclerosis by nuclear magnetic resonance.
    Barkhof F; van Walderveen M
    Philos Trans R Soc Lond B Biol Sci; 1999 Oct; 354(1390):1675-86. PubMed ID: 10603619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conventional and magnetization transfer MRI predictors of clinical multiple sclerosis evolution: a medium-term follow-up study.
    Rovaris M; Agosta F; Sormani MP; Inglese M; Martinelli V; Comi G; Filippi M
    Brain; 2003 Oct; 126(Pt 10):2323-32. PubMed ID: 12937086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI studies of multiple sclerosis: implications for the natural history of the disease and for monitoring effectiveness of experimental therapies.
    McFarland HF; Stone LA; Calabresi PA; Maloni H; Bash CN; Frank JA
    Mult Scler; 1996 Nov; 2(4):198-205. PubMed ID: 9345374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment effects of immunomodulatory therapies at different stages of multiple sclerosis in short-term trials.
    Bates D
    Neurology; 2011 Jan; 76(1 Suppl 1):S14-25. PubMed ID: 21205678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs clinical findings in determining disease activity.
    Barkhof F; Scheltens P; Frequin ST; Nauta JJ; Tas MW; Valk J; Hommes OR
    AJR Am J Roentgenol; 1992 Nov; 159(5):1041-7. PubMed ID: 1414773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Magnetic resonance imaging in multiple sclerosis].
    Tourbah A; Berry I
    Pathol Biol (Paris); 2000 Mar; 48(2):151-61. PubMed ID: 10815291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Value of MRI in patients with multiple sclerosis].
    Tourbah A
    Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):1124-7. PubMed ID: 11787344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Magnetic resonance in the diagnosis and treatment of multiple sclerosis].
    Rovira Cañellas A
    Neurologia; 2000; 15(7):288-302. PubMed ID: 11075577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies for optimizing MRI techniques aimed at monitoring disease activity in multiple sclerosis treatment trials.
    Barkhof F; Filippi M; Miller DH; Tofts P; Kappos L; Thompson AJ
    J Neurol; 1997 Feb; 244(2):76-84. PubMed ID: 9120500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The interferon beta therapy after the first clinical episode of demyelination in multiple sclerosis].
    Demina TL; Khachanova NV; Davydovskaia MV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(3):15-9. PubMed ID: 16608106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.